Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Mushfiquddin Khan and Inderjit Singh.
Connection Strength

13.069
  1. Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms. Neural Regen Res. 2022 Jan; 17(1):185-193.
    View in: PubMed
    Score: 0.854
  2. GSNOR and ALDH2 alleviate traumatic spinal cord injury. Brain Res. 2021 05 01; 1758:147335.
    View in: PubMed
    Score: 0.801
  3. Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke. Brain Res. 2020 08 15; 1741:146879.
    View in: PubMed
    Score: 0.761
  4. S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke. J Stroke Cerebrovasc Dis. 2019 Dec; 28(12):104470.
    View in: PubMed
    Score: 0.735
  5. Therapeutic exploitation of the S-nitrosoglutathione/S-nitrosylation mechanism for the treatment of contusion spinal cord injury. Neural Regen Res. 2019 Jun; 14(6):973-974.
    View in: PubMed
    Score: 0.714
  6. Inhibition of the AMPK/nNOS pathway for neuroprotection in stroke. Neural Regen Res. 2016 Mar; 11(3):398-9.
    View in: PubMed
    Score: 0.570
  7. An NO/GSNO-based Neuroregeneration Strategy for Stroke Therapy. J Neurol Neurosci. 2015; 6(4).
    View in: PubMed
    Score: 0.563
  8. Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy. BMC Neurosci. 2015 Jul 15; 16:42.
    View in: PubMed
    Score: 0.545
  9. Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats. J Neuroinflammation. 2015 May 15; 12:94.
    View in: PubMed
    Score: 0.539
  10. S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J Neuroinflammation. 2011 Jul 06; 8:78.
    View in: PubMed
    Score: 0.413
  11. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J Lipid Res. 2010 Jul; 51(7):1685-95.
    View in: PubMed
    Score: 0.375
  12. Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflammation. 2009 Nov 04; 6:32.
    View in: PubMed
    Score: 0.368
  13. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J Neurochem. 2008 Aug; 106(4):1766-79.
    View in: PubMed
    Score: 0.333
  14. Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide. 2006 Sep; 15(2):114-24.
    View in: PubMed
    Score: 0.285
  15. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab. 2005 Feb; 25(2):177-92.
    View in: PubMed
    Score: 0.264
  16. Asymmetric dimethylarginine-induced oxidative damage leads to cerebrovascular dysfunction. Neural Regen Res. 2021 Sep; 16(9):1793-1794.
    View in: PubMed
    Score: 0.209
  17. Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis. Immunology. 2021 11; 164(3):602-616.
    View in: PubMed
    Score: 0.207
  18. Regulation of B cell functions by S-nitrosoglutathione in the EAE model. Redox Biol. 2021 09; 45:102053.
    View in: PubMed
    Score: 0.206
  19. Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases. Immunology. 2021 09; 164(1):31-42.
    View in: PubMed
    Score: 0.204
  20. Detoxification of Reactive Aldehydes by Alda-1 Treatment Ameliorates Experimental Autoimmune Encephalomyelitis in Mice. Neuroscience. 2021 03 15; 458:31-42.
    View in: PubMed
    Score: 0.200
  21. Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis. Ann Hepatol. 2020 Sep - Oct; 19(5):466-471.
    View in: PubMed
    Score: 0.185
  22. Amelioration of spinal cord injury in rats by blocking peroxynitrite/calpain activity. BMC Neurosci. 2018 08 13; 19(1):50.
    View in: PubMed
    Score: 0.169
  23. Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI. J Neurosci Res. 2018 12; 96(12):1900-1913.
    View in: PubMed
    Score: 0.168
  24. S-Nitrosylation in Regulation of Inflammation and Cell Damage. Curr Drug Targets. 2018; 19(15):1831-1838.
    View in: PubMed
    Score: 0.162
  25. Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury. Neural Regen Res. 2017 May; 12(5):696-701.
    View in: PubMed
    Score: 0.154
  26. GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1a. Behav Brain Res. 2018 03 15; 340:63-70.
    View in: PubMed
    Score: 0.149
  27. S-Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide-induced sepsis. J Pharm Pharmacol. 2016 Oct; 68(10):1310-9.
    View in: PubMed
    Score: 0.147
  28. Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy. PLoS One. 2015; 10(11):e0143238.
    View in: PubMed
    Score: 0.140
  29. Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI. Brain Res. 2016 Jan 01; 1630:159-70.
    View in: PubMed
    Score: 0.140
  30. Promoting endothelial function by S-nitrosoglutathione through the HIF-1a/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats. Drug Des Devel Ther. 2015; 9:2233-47.
    View in: PubMed
    Score: 0.134
  31. S-Nitrosoglutathione protects the spinal bladder: novel therapeutic approach to post-spinal cord injury bladder remodeling. Neurourol Urodyn. 2015 Aug; 34(6):519-26.
    View in: PubMed
    Score: 0.126
  32. Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells. PLoS One. 2013; 8(7):e70712.
    View in: PubMed
    Score: 0.119
  33. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes. Biochim Biophys Acta. 2013 Apr; 1831(4):747-58.
    View in: PubMed
    Score: 0.115
  34. Simvastatin ameliorates cauda equina compression injury in a rat model of lumbar spinal stenosis. J Neuroimmune Pharmacol. 2013 Mar; 8(1):274-86.
    View in: PubMed
    Score: 0.114
  35. The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke. J Neurochem. 2012 Nov; 123 Suppl 2:86-97.
    View in: PubMed
    Score: 0.113
  36. S-Nitrosoglutathione administration ameliorates cauda equina compression injury in rats. Neurosci Med. 2012 Sep 25; 3(3):294-305.
    View in: PubMed
    Score: 0.112
  37. Spinal cord injury induced arrest in estrous cycle of rats is ameliorated by S-nitrosoglutathione: novel therapeutic agent to treat amenorrhea. J Sex Med. 2012 Jan; 9(1):148-58.
    View in: PubMed
    Score: 0.105
  38. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes. J Lipid Res. 2011 Nov; 52(11):2056-69.
    View in: PubMed
    Score: 0.104
  39. Simvastatin protects bladder and renal functions following spinal cord injury in rats. J Inflamm (Lond). 2010 Apr 19; 7:17.
    View in: PubMed
    Score: 0.095
  40. Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. J Neuroinflammation. 2009 Aug 13; 6:21.
    View in: PubMed
    Score: 0.090
  41. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy. J Lipid Res. 2009 Jan; 50(1):135-47.
    View in: PubMed
    Score: 0.085
  42. Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts. J Neurochem. 2008 May; 105(4):1536-49.
    View in: PubMed
    Score: 0.081
  43. Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem. 2007 Jul; 102(2):365-77.
    View in: PubMed
    Score: 0.077
  44. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond). 2006 Aug 10; 3:31.
    View in: PubMed
    Score: 0.073
  45. Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J Neuroinflammation. 2006 May 11; 3:12.
    View in: PubMed
    Score: 0.072
  46. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB J. 2005 Sep; 19(11):1407-21.
    View in: PubMed
    Score: 0.069
  47. Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide-induced inducible nitric oxide synthase expression in glial cells. Glia. 2005 Jul; 51(1):13-21.
    View in: PubMed
    Score: 0.068
  48. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J Neurosci Res. 2005 Jun 15; 80(6):845-54.
    View in: PubMed
    Score: 0.068
  49. Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients. Mol Genet Metab. 2004 Dec; 83(4):297-305.
    View in: PubMed
    Score: 0.065
  50. Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. Brain Res. 2004 Oct 01; 1022(1-2):1-11.
    View in: PubMed
    Score: 0.065
  51. Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic Biol Med. 2004 Aug 01; 37(3):325-38.
    View in: PubMed
    Score: 0.064
  52. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J Neurosci. 2004 Jun 30; 24(26):5942-54.
    View in: PubMed
    Score: 0.063
  53. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res. 2004 May 15; 76(4):519-27.
    View in: PubMed
    Score: 0.063
  54. The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase. J Neurochem. 2004 Feb; 88(3):583-93.
    View in: PubMed
    Score: 0.062
  55. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis. 2003 Dec; 14(3):425-39.
    View in: PubMed
    Score: 0.061
  56. Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology. FASEB J. 2020 05; 34(5):6808-6823.
    View in: PubMed
    Score: 0.047
  57. Regulation of endothelial barrier integrity by redox-dependent nitric oxide signaling: Implication in traumatic and inflammatory brain injuries. Nitric Oxide. 2019 02 01; 83:51-64.
    View in: PubMed
    Score: 0.043
  58. Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion. Restor Neurol Neurosci. 2012; 30(5):383-96.
    View in: PubMed
    Score: 0.027
  59. Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol. 2011 Aug; 179(2):703-13.
    View in: PubMed
    Score: 0.026
  60. Preclinical use of longitudinal MRI for screening the efficacy of S-nitrosoglutathione in treating spinal cord injury. J Magn Reson Imaging. 2011 Jun; 33(6):1301-11.
    View in: PubMed
    Score: 0.026
  61. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]. Lab Invest. 2010 May; 90(5):696-708.
    View in: PubMed
    Score: 0.023
  62. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J Neurochem. 2008 Jun; 105(5):1820-33.
    View in: PubMed
    Score: 0.020
  63. Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem. 2008 May; 105(3):956-70.
    View in: PubMed
    Score: 0.020
  64. N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res. 2003 May 02; 971(1):1-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.